PRICE T ROWE ASSOCIATES INC /MD/ - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 100 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,823
+31.0%
210,352
-5.8%
0.00%0.0%
Q2 2023$3,682
+20.2%
223,237
+30.1%
0.00%
Q1 2023$3,062
+639.6%
171,580
+1108.3%
0.00%
Q4 2022$414
-99.9%
14,200
-12.9%
0.00%
Q3 2022$400,000
+168.5%
16,300
+26.4%
0.00%
Q1 2022$149,000
-31.7%
12,900
-22.8%
0.00%
Q3 2021$218,000
-33.3%
16,7120.0%0.00%
Q2 2021$327,000
-0.6%
16,712
+8.1%
0.00%
Q1 2021$329,000
-27.5%
15,465
+1.3%
0.00%
Q4 2020$454,000
-97.6%
15,270
-98.2%
0.00%
-100.0%
Q4 2019$19,217,000
+3.9%
836,985
-2.3%
0.00%
-33.3%
Q3 2019$18,488,000
-21.6%
856,324
-20.1%
0.00%0.0%
Q2 2019$23,585,000
-14.6%
1,072,041
+6.4%
0.00%
-25.0%
Q1 2019$27,613,000
+29.5%
1,007,416
+27.0%
0.00%0.0%
Q4 2018$21,323,000
-7.5%
793,274
+0.4%
0.00%
+33.3%
Q3 2018$23,045,000
+33.1%
790,015
+42.6%
0.00%0.0%
Q2 2018$17,314,000
+105.7%
553,885
+30.9%
0.00%
+200.0%
Q1 2018$8,419,000
-4.7%
423,049
+39.1%
0.00%0.0%
Q4 2017$8,838,000304,1270.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$11,875,0002.75%
RA Capital Management 4,871,067$63,616,0000.88%
NEA Management Company, LLC 4,912,306$64,155,0000.76%
Samsara BioCapital, LLC 300,293$3,922,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,989,625$25,985,0000.51%
Baker Brothers Advisors 3,863,239$50,454,0000.22%
ACT CAPITAL MANAGEMENT, LLC 31,000$405,0000.21%
Rock Springs Capital Management LP 612,180$7,995,0000.17%
GILDER GAGNON HOWE & CO LLC 1,496,424$19,543,0000.10%
FEDERATED HERMES, INC. 3,011,053$39,324,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders